Fennec Pharmaceuticals (FENC) Times Interest Earned (2021 - 2025)
Historic Times Interest Earned for Fennec Pharmaceuticals (FENC) over the last 10 years, with Q3 2025 value amounting to -$0.32.
- Fennec Pharmaceuticals' Times Interest Earned rose 9364.5% to -$0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7, marking a year-over-year decrease of 50634.96%. This contributed to the annual value of $0.63 for FY2024, which is 11677.24% up from last year.
- Per Fennec Pharmaceuticals' latest filing, its Times Interest Earned stood at -$0.32 for Q3 2025, which was up 9364.5% from -$4.6 recorded in Q2 2025.
- Over the past 5 years, Fennec Pharmaceuticals' Times Interest Earned peaked at $13.29 during Q1 2024, and registered a low of -$1230.8 during Q1 2021.
- Its 5-year average for Times Interest Earned is -$110.41, with a median of -$5.37 in 2023.
- Within the past 5 years, the most significant YoY rise in Fennec Pharmaceuticals' Times Interest Earned was 30125.81% (2024), while the steepest drop was 32716.86% (2024).
- Over the past 5 years, Fennec Pharmaceuticals' Times Interest Earned (Quarter) stood at -$75.87 in 2021, then skyrocketed by 86.2% to -$10.47 in 2022, then soared by 81.03% to -$1.99 in 2023, then surged by 51.34% to -$0.97 in 2024, then soared by 66.64% to -$0.32 in 2025.
- Its Times Interest Earned stands at -$0.32 for Q3 2025, versus -$4.6 for Q2 2025 and -$1.36 for Q1 2025.